Importantly, the current clinical landscape reflects ongoing interest in this concept: while Roche has discontinued development of an NPY2R agonist, Gubra is advancing an NPY2R program in collaboration with Boehringer Ingelheim, suggesting that the hypothesis of pharmacologically optimized Y2 receptor engagement retains translational credibility
It does not provide medical advice, determine appropriate doses, prescribe or recommend peptides, or replace licensed clinician guidance
levez votre entranement et votre condition physique au prochain niveau.
Can I combine AOD-9604 with other peptides or weight loss treatments
Conclusion Getting weight loss injections on the NHS in 2026 is possible, but it is not straightforward
Animal studies have suggested that GLP-1 receptors are expressed in various brain regions, including areas involved in stress response regulation